The Soft Tissue Sarcoma market is witnessing significant developments as a result of advancements in cancer research, increased understanding of tumor biology, and the emergence of targeted therapies. Soft tissue sarcomas, a diverse group of rare cancers, Surgical resection, often present therapeutic challenges due to their variability in histological subtypes. The market includes a spectrum of...